Perspective Therapeutics, Inc. Stock
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | -2.78% | -3.31% | +335.32% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 47.25K | Capitalization | 1.03B |
---|---|---|---|---|---|
Net income 2024 * | -53M | Net income 2025 * | -58M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 16,303 x |
P/E ratio 2024 * |
-17.9
x | P/E ratio 2025 * |
-15.1
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.58% |
Latest transcript on Perspective Therapeutics, Inc.
1 day | -2.78% | ||
1 week | -3.31% | ||
Current month | +4.17% | ||
1 month | +15.13% | ||
3 months | +94.42% | ||
6 months | +644.68% | ||
Current year | +335.32% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 52 | 23-02-02 |
Mark Austin
DFI | Director of Finance/CFO | 37 | 17-06-30 |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 23-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 23-05-31 |
Lori Woods
CHM | Chairman | 61 | 23-02-02 |
Director/Board Member | 58 | 23-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.75 | -2.78% | 4,905,770 |
24-05-09 | 1.8 | +2.27% | 6,022,023 |
24-05-08 | 1.76 | -4.35% | 5,109,997 |
24-05-07 | 1.84 | +0.55% | 3,917,512 |
24-05-06 | 1.83 | +1.10% | 2,971,983 |
Delayed Quote Nyse, May 10, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+335.32% | 1.03B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- CATX Stock